Diabetes and insulin resistance in the neuropsychiatric population

Research output: Contribution to journalArticle

Abstract

Incidence of diabetes in the general population has increased dramatically in recent years. In only 9 states is the current prevalence of diabetes below 6%. Persons with mental illness are at higher risk for diabetes because of a variety of factors; incidence of diabetes in schizophrenic persons is estimated at about 10%. Insulin resistance can precede the development of diabetes by several years. Mental health professionals as well as primary care physicians should screen patients with mental illness for signs of insulin resistance and diabetes before starting therapy with antipsychotic medications. Patients receiving antipsychotic medications should also have their blood glucose levels monitored regularly so that any metabolic disturbances that may arise can be evaluated and treated promptly.

Original languageEnglish (US)
Pages (from-to)18-23
Number of pages6
JournalDrug Benefit Trends
Volume15
Issue numberSUPPL. B
StatePublished - Apr 1 2003

Fingerprint

Antipsychotic Agents
Insulin Resistance
Incidence
Mentally Ill Persons
Primary Care Physicians
Population
Blood Glucose
Mental Health
Delivery of Health Care
Therapeutics

All Science Journal Classification (ASJC) codes

  • Health Policy
  • Pharmacology (medical)

Cite this

Diabetes and insulin resistance in the neuropsychiatric population. / Dagogo-Jack, Samuel.

In: Drug Benefit Trends, Vol. 15, No. SUPPL. B, 01.04.2003, p. 18-23.

Research output: Contribution to journalArticle

@article{18f7326af6eb47f3a346916f1785af02,
title = "Diabetes and insulin resistance in the neuropsychiatric population",
abstract = "Incidence of diabetes in the general population has increased dramatically in recent years. In only 9 states is the current prevalence of diabetes below 6{\%}. Persons with mental illness are at higher risk for diabetes because of a variety of factors; incidence of diabetes in schizophrenic persons is estimated at about 10{\%}. Insulin resistance can precede the development of diabetes by several years. Mental health professionals as well as primary care physicians should screen patients with mental illness for signs of insulin resistance and diabetes before starting therapy with antipsychotic medications. Patients receiving antipsychotic medications should also have their blood glucose levels monitored regularly so that any metabolic disturbances that may arise can be evaluated and treated promptly.",
author = "Samuel Dagogo-Jack",
year = "2003",
month = "4",
day = "1",
language = "English (US)",
volume = "15",
pages = "18--23",
journal = "Drug Benefit Trends",
issn = "1080-5826",
publisher = "Cliggott Publishing Co.",
number = "SUPPL. B",

}

TY - JOUR

T1 - Diabetes and insulin resistance in the neuropsychiatric population

AU - Dagogo-Jack, Samuel

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Incidence of diabetes in the general population has increased dramatically in recent years. In only 9 states is the current prevalence of diabetes below 6%. Persons with mental illness are at higher risk for diabetes because of a variety of factors; incidence of diabetes in schizophrenic persons is estimated at about 10%. Insulin resistance can precede the development of diabetes by several years. Mental health professionals as well as primary care physicians should screen patients with mental illness for signs of insulin resistance and diabetes before starting therapy with antipsychotic medications. Patients receiving antipsychotic medications should also have their blood glucose levels monitored regularly so that any metabolic disturbances that may arise can be evaluated and treated promptly.

AB - Incidence of diabetes in the general population has increased dramatically in recent years. In only 9 states is the current prevalence of diabetes below 6%. Persons with mental illness are at higher risk for diabetes because of a variety of factors; incidence of diabetes in schizophrenic persons is estimated at about 10%. Insulin resistance can precede the development of diabetes by several years. Mental health professionals as well as primary care physicians should screen patients with mental illness for signs of insulin resistance and diabetes before starting therapy with antipsychotic medications. Patients receiving antipsychotic medications should also have their blood glucose levels monitored regularly so that any metabolic disturbances that may arise can be evaluated and treated promptly.

UR - http://www.scopus.com/inward/record.url?scp=0038730966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038730966&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0038730966

VL - 15

SP - 18

EP - 23

JO - Drug Benefit Trends

JF - Drug Benefit Trends

SN - 1080-5826

IS - SUPPL. B

ER -